Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological MalignanciesZainab Shahid, Joshua A. Hill, Paul A. Carpenter et al.|Transplantation and Cellular Therapy|2024Cited by 78
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019Evan M. Bloch, Kelly A. Gebo, Daniele Focosi et al.|Clinical Infectious Diseases|2023Cited by 52
Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ diseaseAndrew H. Karaba, Robin K. Avery, Alexis Figueroa et al.|Transplant Infectious Disease|2021Cited by 6
Multiple dimensions of neurological injury in a liver transplant recipient with cryptococcal meningitisShmuel Shoham, Arturo Casadevall, Sabin Thapaliya et al.|ASM Case Reports|2024Cited by 1
Comparison of outcomes in sot recipients during two eras of covid-19 therapeuticsTung‐Chuan Chiang, Robin K. Avery, Afrah S. Sait et al.|American Journal of Transplantation|2021Cited by 0